Active Shortage Injection Anesthesia
Dexmedetomidine Hydrochlorid · 2,341 days since initial FDA posting
Brand: PRECEDEX
FDA lists Dexmedetomidine Hydrochlorid as Active Shortage (Pfizer Inc.).
Availability on file: Available
Dexmedetomidine Hydrochloride Injection: Active Shortage
Available Contact your pharmacist if you are affected.
Shortage Details
- Generic Name
- Dexmedetomidine Hydrochloride Injection
- Manufacturer
- Pfizer Inc.
- Dosage Form
- Injection
- Presentation
- Precedex, Injection, 400 mcg/100 mL (4 mcg/mL) (NDC 0409-1174-10)
- Package NDC
- 0409-1174-10
Status & Timeline
- Status
- Active Shortage
- Availability
- Available
- First Reported
- Apr 10, 2020
- Last Updated
- Mar 13, 2026
- Therapeutic Category
- Anesthesia
Row fields from the FDA Drug Shortages database via openFDA.
Nearby, Other Dexmedetomidine Shortage Records
Dexmedetomidine Hydrochloride Injection
Gland Pharma Limited
Injection
Dexmedetomidine Hydrochloride Injection
Gland Pharma Limited
Injection
Dexmedetomidine Hydrochloride Injection
Gland Pharma Limited
Injection
Dexmedetomidine Hydrochloride Injection
Slayback Pharma
Injection
Dexmedetomidine Hydrochloride Injection
Slayback Pharma
Injection
Dexmedetomidine Hydrochloride Injection
Meitheal Pharmaceuticals, Inc.
Injection